CNSP CNS Pharmaceuticals, Inc.: Company Short-Term Debts

Symbol and logo of brand CNS Pharmaceuticals Corp (CNSP)

By optimizing transport routes and establishing warehouse reserves, CNS Pharmaceuticals (CNSP) eliminates raw material supply disruptions. This stock price chart demonstrates the dynamics of the company, whose metrics stand at 0.00. The business relies on unique patents for crossing the blood-brain barrier under strict FDA supervision. Additionally, a climate control system has been implemented for the delivery of medications to medical centers.

CNSP CNS Pharmaceuticals Inc Company Short-Term Loans and Borrowings (07/04/2022 - 11/01/2026)

CNS Pharmaceuticals Corp - analytical breakdowns and key metrics (CNSP)

- stock price and consensus target price:
Stock Price CNS Pharmaceuticals, Inc.|CNSP - Consensus Target
- company stock capitalization data:
Market Capitalization CNS Pharmaceuticals, Inc.|CNSP - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share CNS Pharmaceuticals|CNSP - Accounting Value of Company|Market Cap to Net Assets Ratio cnspharma.com|CNSP - Aggregate Asset Value
- debt and liquidity details:
Total Debt to Capital CNS Pharmaceuticals|CNSP - Long-Term Debt to Equity|Short-Term Debt to Equity CNS Pharmaceuticals|CNSP - Aggregate Debt Obligations|Debts to Book Capitalization CNS Pharmaceuticals, Inc.|CNSP - Company Long-Term Debts|Company Short-Term Debts CNS Pharmaceuticals|Quick Liquidity cnspharma.com
- earnings and multiples data:
CNSP - Company Profit
General company analysis:CNS Pharmaceuticals, Inc. (CNSP)
Manufactured products of CNS Pharmaceuticals

Short-term debt measures the aggregate of credit obligations with maturities of up to twelve months intended to maintain operational liquidity. By analyzing the dynamics of short-term credit obligations, an investor assesses the risk of cash flow gaps for CNS Pharmaceuticals (CNSP) while financing the development and market launch of the innovative drug berubicine for the therapy of aggressive brain tumors until insurance payments are received.

Competitors of CNS Pharmaceuticals (CNSP)

Shuttle Pharmaceuticals Holdings - Company Short-Term Debts